Lakewood-Amedex Biotherapeutics (LABT) vs Oragenics (OGEN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Oragenics is the larger company by market cap ($2.1 million vs $1.9 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LABT | OGEN |
|---|---|---|
| Share price | $0.792 | $0.463 |
| Market cap | $1.88M | $2.09M |
| 1-day change | -6.80% | -7.38% |
| EPS (TTM) | $-8.83 | $-2.63 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $98.20 | $1.45 |
| 52-week low | $0.76 | $0.46 |
| Distance from 52-week high | -99.19% | -68.07% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +1415.15% | — |
| Average volume | 2.50M | 29.43K |
| Shares outstanding | 2.37M | 4.51M |
| Employees | 5 | 3 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Lakewood-Amedex Biotherapeutics
LABT stock →Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.
Healthcare · Biotechnology · 5 employees
About Oragenics
OGEN stock →Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury.
Healthcare · Biotechnology · 3 employees
LABT vs OGEN FAQ
Which is bigger, Lakewood-Amedex Biotherapeutics or Oragenics?
Oragenics (OGEN) is larger, with a market capitalization of $2.09M compared with $1.88M for Lakewood-Amedex Biotherapeutics (LABT).
Are Lakewood-Amedex Biotherapeutics and Oragenics in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.